Bionomics Publishes the Positive Results from the Phase 2 ATTUNE Study of BNC210 in Patients with Post-Traumatic Stress Disorder in NEJM Evidence
BNC210 improved PTSD symptom severity at Week 12 with efficacy observed as early as Week 4Company plans to initiate a Phase 3 study of BNC210 in ...
Le Lézard1d
Media Alert: NightWare Launches Campaign to Disrupt Sleep
NightWare, the manufacturer of the FDA-cleared digital therapeutic device that treats PTSD-related nightmares, announced today that it has launched an equity crowdfunding campaign on StartEngine. The ...
BMJ1d
Retrospective delirium ascertainment from case notes: a retrospective cohort study
This project was performed as a substudy within a larger quality improvement project; the date were chosen as it was 6 months before and after the dates of separate prospective data collection. We ...